Bioinformatics analysis of immune-related prognostic genes and immunotherapy in renal clear cell carcinoma.
Ziwen PanSheng ChangSong ChenDaqiang ZhaoZhiyu ZouLinrui DaiYibo HouQianqian ZhangYuanyuan YangZhishui ChenWeijie ZhangYuanyuan ZhaoPublished in: PloS one (2022)
Clear cell renal cell carcinoma (ccRCC) is an immunogenic tumor, and investigating the immunorelated genes is essential. To investigate the immunoprognostic genes of ccRCC, we analyzed the data assimilated from a public database (The Cancer Genome Atlas (TCGA) database and the gene expression omnibus (GEO) database) using bioinformatics. Then, an immunoprognosis model was constructed to identify four hub genes with moderate predictive values for the prognosis of ccRCC patients. These four genes were associated with the prognosis of ccRCC patients based on Oncomine and Gena Expression Profiling Interactive Analysis (GEPIA) databases. The correlation analysis between the immune infiltrate, immune checkpoints, and immunotherapy and this immunoprognosis model showed that immune infiltration could predict the immunotherapy effects. We also conducted a quantitative real-time polymerase chain reaction analysis and found that the expressions of three hub genes were associated with tumor progression (P<0.1). In conclusion, four genes that may serve as potential biomarkers in ccRCC were identified with respect to prognosis.
Keyphrases
- bioinformatics analysis
- genome wide
- gene expression
- genome wide identification
- end stage renal disease
- newly diagnosed
- dna methylation
- chronic kidney disease
- healthcare
- peritoneal dialysis
- genome wide analysis
- prognostic factors
- mental health
- squamous cell carcinoma
- poor prognosis
- emergency department
- transcription factor
- papillary thyroid
- mass spectrometry
- adverse drug
- long non coding rna
- artificial intelligence
- lymph node metastasis
- big data
- squamous cell